Suraksha Diagnostic Declares Unaudited Q1 FY27 Results

Suraksha Diagnostic Ltd announced the approval of its unaudited financial results for the quarter ended June 30, 2026, on a standalone and consolidated basis. The Board of Directors also approved the revised notice for the 21st Annual General Meeting, scheduled for September 22, 2026. Additionally, September 15, 2026, was fixed as the record date for determining shareholder entitlement to dividends for the financial year ended March 31, 2026. The company also announced the appointment of Mr. Dinesh Gupta as the Chief Financial Officer, effective August 24, 2026.